Similarly, in the CT26 tumors, the competency of AH1 tumor antigen-specific CD8+ T cells to produce IFN-γ and TNF-α was increased with combination treatment relative to control or single agent-treated mice. The gene discussed is IFNG; the disease is neoplasm.